Release test results
99.731%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.06 mg
Related impurities (total)0.269%
Endotoxin<1.0 EU/mg
HPLC retention time8.73 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundSS-31 (Elamipretide)
Presentation10 MG
Lot numberRGX-26-SS-1032
COA numberNS-2026-05033
Test date23 Jul 2026
Release date26 Jul 2026
Independent labNordicstar Labs
StatusCurrent
SS-31 (Elamipretide) — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-SS-1032 this lot | 10 MG | Jul 23, 2026 | 99.731% | Current |
| RGX-26-SS-1033 | 50 MG | Jul 22, 2026 | 99.555% | Current |
| RGX-26-SS-768 | 10 MG | Apr 8, 2026 | 99.746% | Superseded |
| RGX-26-SS-767 | 50 MG | Apr 4, 2026 | 99.704% | Superseded |
| RGX-26-SS-668 | 10 MG | Jan 24, 2026 | 99.742% | Superseded |
| RGX-26-SS-667 | 50 MG | Jan 5, 2026 | 99.666% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →